7-Fluoro-3-methyl-2,3-dihydro-4H-1,3-benzoxazin-4-one → HCID 15949864, Verbindung
Reaktionsgleichung
F[C:2]1[CH:13]=[CH:12][C:5]2[C:6](=[O:11])[N:7]([CH3:10])[CH2:8][O:9][C:4]=2[CH:3]=1.[OH:14][C:15]1[CH:16]=[C:17]([CH:28]=[C:29]([O:31][C@H:32]2[CH2:36][CH2:35][O:34][CH2:33]2)[CH:30]=1)[C:18]([NH:20][C:21]1[CH:26]=[N:25][C:24]([CH3:27])=[CH:23][N:22]=1)=[O:19]>>[CH3:10][N:7]1[C:6](=[O:11])[C:5]2[CH:12]=[CH:13][C:2]([O:14][C:15]3[CH:16]=[C:17]([CH:28]=[C:29]([O:31][C@H:32]4[CH2:36][CH2:35][O:34][CH2:33]4)[CH:30]=3)[C:18]([NH:20][C:21]3[CH:26]=[N:25][C:24]([CH3:27])=[CH:23][N:22]=3)=[O:19])=[CH:3][C:4]=2[O:9][CH2:8]1Komponenten
3
Versuchsvorschrift
The preparations of 7-fluoro-3-methyl-2,3-dihydro-4H-1,3-benzoxazin-4-one and 3-hydroxy-N-(5-methylpyrazin-2-yl)-5-[(3S)-tetrahydrofuran-3-yloxy]benzamide were described earlier.
Quellen und Nachweise
- ORD-Eintrag
- ord-727d11c02e1d4dfe9fc385025113a72f
- Quelldatensatz
- uspto-grants-2011_05